Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Nature Communications

Volumn 7, Issue , 2016, Pages

  Couch, Fergus J ^a   Kuchenbaecker, Karoline B ^b   Michailidou, Kyriaki ^c   Mendoza Fandino, Gustavo A ^d   Nord, Silje ^e   Lilyquist, Janna ^f   Olswold, Curtis ^f   Hallberg, Emily ^f   Agata, Simona ^g   Ahsan, Habibul ^h   Aittomäki, Kristiina ^k   Ambrosone, Christine ^l   Andrulis, Irene L ^m   Anton Culver, Hoda ^o   Arndt, Volker ^p   Arun, Banu K ^q   Arver, Brita ^r   Barile, Monica ^s   Barkardottir, Rosa B ^s   Barrowdale, Daniel ^t   Beckmann, Lars ^u   Beckmann, Matthias W ^g   Benitez, Javier ^v   Blank, Stephanie V ^y   Blomqvist, Carl ^l   Bogdanova, Natalia V ^z   Bojesen, Stig E ^aa   Bolla, Manjeet K ^ab   Bonanni, Bernardo ^ac   Brauch, Hiltrud ^ad   Brenner, Hermann ^af   Burwinkel, Barbara ^ah   Buys, Saundra S ^ah   Caldes, Trinidad ^a   Caligo, Maria A ^ai   Canzian, Federico ^aj   Carpenter, Jane ^ak   Chang Claude, Jenny ^al   Chanock, Stephen J ^am   Chung, Wendy K ^an   Claes, Kathleen B M ^ao   Cox, Angela ^ap   Cross, Simon S ^aq   Cunningham, Julie M ^ar   Czene, Kamila ^z,ae   Daly, Mary B ^at   Damiola, Francesca ^au   Darabi, Hatef ^av   De La Hoya, Miguel ^r   Devilee, Peter ^aw   Diez, Orland ^ax   Ding, Yuan C ^ay   Dolcetti, Riccardo ^az,bj   Domchek, Susan M ^ba,bl   Dorfling, Cecilia M ^bb   Dos Santos Silva, Isabel ^bc   Dumont, Martine ^bd   Dunning, Alison M ^be   Eccles, Diana M ^bf   Ehrencrona, Hans ^bg   Ekici, Arif B ^bi   Eliassen, Heather ^bk   Ellis, Steve ^bm   Fasching, Peter A ^bc   Figueroa, Jonine ^bn   Flesch Janys, Dieter ^aa   Försti, Asta ^s   Fostira, Florentia ^bo   Foulkes, William D ^bp   Friebel, Tara ^bq   Friedman, Eitan ^br   Frost, Debra ^l   Gabrielson, Marike ^bk   Gammon, Marilie D ^bs   Ganz, Patricia A ^g   Gapstur, Susan M ^bt   Garber, Judy ^bu   Gaudet, Mia M ^bj,bv   Gayther, Simon A ^bw   Gerdes, Anne Marie ^bx   Ghoussaini, Maya ^ay   Giles, Graham G ^as   Glendon, Gord ^bz   Godwin, Andrew K ^ca   Goldberg, Mark S ^cb   Goldgar, David E ^cd   González Neira, Anna ^g   Greene, Mark H ^h   Gronwald, Jacek ^g   Guénel, Pascal ^ce,cg   Gunter, Marc ^g   Haeberle, Lothar ^i,cn   Haiman, Christopher A ^br,ch   Hamann, Ute ^ci   Hansen, Thomas V O ^cj,da   Hart, Steven ^ck,dk   Healey, Sue ^cl   Heikkinen, Tuomas ^cm   Henderson, Brian E ^cf,do   Herzog, Josef ^co   Hogervorst, Frans B L ^ai,dw   Hollestelle, Antoinette ^cp   Hooning, Maartje J ^ay,eb   Hoover, Robert N ^cq   Hopper, John L ^cr   Humphreys, Keith ^cs   Hunter, David J ^ct,em   Huzarski, Tomasz ^cu,en   Imyanitov, Evgeny N ^cv   Isaacs, Claudine ^h   Jakubowska, Anna ^cw   James, Paul ^cx   Janavicius, Ramunas ^cz   Jensen, Uffe Birk ^cy   John, Esther M ^db   Jones, Michael ^dc   Kabisch, Maria ^dd   Kar, Siddhartha ^de   Karlan, Beth Y ^df   Khan, Sofia ^dg   Khaw, Kay Tee ^dh   Kibriya, Muhammad G ^di   Knight, Julia A ^cf   Ko, Yon Dschun ^dj   Konstantopoulou, Irene ^l   Kosma, Veli Matti ^dl   Kristensen, Vessela ^dm   Kwong, Ava ^dn   Laitman, Yael ^dp   Lambrechts, Diether ^af   Lazaro, Conxi ^dq   Lee, Eunjung ^dr   Le Marchand, Loic ^dr   Lester, Jenny ^ds   Lindblom, Annika ^dt   Lindor, Noralane ^du   Lindstrom, Sara ^dv   Liu, Jianjun ^cb   Long, Jirong ^v   Lubinski, Jan ^dx   Mai, Phuong L ^dy   Makalic, Enes ^dz   Malone, Kathleen E ^ea   Mannermaa, Arto ^ec   Manoukian, Siranoush ^ed   Margolin, Sara ^ee   Marme, Frederik ^ef   Martens, John W M ^eg   Mcguffog, Lesley ^eh   Meindl, Alfons ^dh   Miller, Austin ^al   Milne, Roger L ^ei   Miron, Penelope ^cn   Montagna, Marco ^ej   Mazoyer, Sylvie ^ek   Mulligan, Anna M ^el   Muranen, Taru A ^ae   Nathanson, Katherine L ^eo   Neuhausen, Susan L ^ep   Nevanlinna, Heli ^eq   Nordestgaard, Børge G ^er   Nussbaum, Robert L ^es   Offit, Kenneth ^ay   Olah, Edith ^er   Olopade, Olufunmilayo I ^es   Olson, Janet E ^ay   Osorio, Ana ^bs   Park, Sue K ^es   Peeters, Petra H ^bu   Peissel, Bernard ^p   Peterlongo, Paolo ^p   Peto, Julian ^ay   Phelan, Catherine M ^by   Pilarski, Robert ^bz   Poppe, Bruce ^m   Pylkäs, Katri ^cb   Radice, Paolo ^cc   Rahman, Nazneen ^cd   Rantala, Johanna ^q   Rappaport, Christine ^r   Rennert, Gad ^s   Richardson, Andrea ^s   Robson, Mark ^t   Romieu, Isabelle ^u   Rudolph, Anja ^g   Rutgers, Emiel J ^v   Sanchez, Maria Jose ^w   Santella, Regina M ^q   Sawyer, Elinor J ^h   Schmidt, Daniel F ⁱ   Schmidt, Marjanka K ^j   Schmutzler, Rita K ^k   Schumacher, Fredrick ⁿ   Scott, Rodney ^o   Senter, Leigha ^p   Sharma, Priyanka ^q   Simard, Jacques ^s   Singer, Christian F ^s   Sinilnikova, Olga M ^s   Soucy, Penny ^u   Southey, Melissa ^g   Steinemann, Doris ^v   Stenmark Askmalm, Marie ^w   Stoppa Lyonnet, Dominique ^x   Swerdlow, Anthony ^r   Szabo, Csilla I ^s   Tamimi, Rulla ^s   Tapper, William ^g   Teixeira, Manuel R ^v   Teo, Soo Hwang ^ag   Terry, Mary B ^ah   Thomassen, Mads ^a   Thompson, Deborah ^ai   Tihomirova, Laima ^aj   Toland, Amanda E ^ak   Tollenaar, Robert A E M ^al   Tomlinson, Ian ^am   Truong, Thérèse ^an   Tsimiklis, Helen ^ao   Teulé, Alex ^ap   Tumino, Rosario ^aq   Tung, Nadine ^ar   Turnbull, Clare ^as   Ursin, Giski ^at   Van Deurzen, Carolien H M ^au   Van Rensburg, Elizabeth J ^av   Varon Mateeva, Raymonda ^r   Wang, Zhaoming ^aw   Wang Gohrke, Shan ^ax   Weiderpass, Elisabete ^ay   Weitzel, Jeffrey N ^bc   Whittemore, Alice ^bd   Wildiers, Hans ^be   Winqvist, Robert ^bf   Yang, Xiaohong R ^bg   Yannoukakos, Drakoulis ^bh   Yao, Song ^q   Zamora, M Pilar ^r   Zheng, Wei ^s   Hall, Per ^s   Kraft, Peter ^t   Vachon, Celine ^v   Slager, Susan ^w   Chenevix Trench, Georgia ^ae   Pharoah, Paul D P ^q   Monteiro, Alvaro A N ^w   García Closas, Montserrat ^bq   Easton, Douglas F ^br   Antoniou, Antonis C ^l   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^f UNIVERSITY OF CHICAGO   (United States)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^m UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁿ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^o EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^p LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^q INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^r UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^s Centro Nacional de Investigaciones Oncológicas   (Spain)

^t CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^u NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v HANNOVER MEDICAL SCHOOL   (Germany)

^w GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^x DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^y UNIVERSITY OF TÜBINGEN   (Germany)

^z UNIVERSITY OF HEIDELBERG   (Germany)

^aa UNIVERSITY OF UTAH   (United States)

^ab HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^ac UNIVERSITY HOSPITAL OF PISA   (Italy)

^ad UNIVERSITY OF SYDNEY   (Australia)

^ae NATIONAL CANCER INSTITUTE   (United States)

^af Och Spine at New York Presbyterian Hospitals   (United States)

^ag GHENT UNIVERSITY HOSPITAL   (Belgium)

^ah UNIVERSITY OF SHEFFIELD   (United Kingdom)

^ai KAROLINSKA INSTITUTE   (Sweden)

^aj FOX CHASE CANCER CENTER   (United States)

^ak CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^al LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^am UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^an CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^ao CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^ap UNIVERSITY OF PENNSYLVANIA   (United States)

^aq UNIVERSITY OF PRETORIA   (South Africa)

^ar LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^as LAVAL UNIVERSITY   (Canada)

^at UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^au UPPSALA UNIVERSITY   (Sweden)

^av LUND UNIVERSITY HOSPITAL   (Sweden)

^aw UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^ax BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ay HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^az UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^ba LUND UNIVERSITY   (Sweden)

^bb INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^bc MCGILL UNIVERSITY   (Canada)

^bd University of the Sciences   (United States)

^be GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^bf UNIVERSITY OF NORTH CAROLINA   (United States)

^bg UNIVERSITY OF CALIFORNIA   (United States)

^bh AMERICAN CANCER SOCIETY   (United States)

^bi DANA FARBER CANCER INSTITUTE   (United States)

^bj CEDARS SINAI MEDICAL CENTER   (United States)

^bk Rigshospitalet   (Denmark)

^bl CANCER EPIDEMIOLOGY CENTRE   (Australia)

^bm UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^bn ROYAL VICTORIA HOSPITAL   (Canada)

^bo POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bp NATIONAL INSTITUTES OF HEALTH   (United States)

^bq IMPERIAL COLLEGE LONDON   (United Kingdom)

^br UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^bs QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^bt Division of Clinical Cancer Genetics   (United States)

^bu NETHERLANDS CANCER INSTITUTE   (Netherlands)

^bv ERASMUS MC CANCER INSTITUTE   (Netherlands)

^bw ERASMUS MEDICAL CENTER   (Netherlands)

^bx UNIVERSITY OF MELBOURNE   (Australia)

^by N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^bz GEORGETOWN UNIVERSITY   (United States)

^ca PETER MACCALLUM CANCER CENTRE   (Australia)

^cb UNIVERSITY OF MELBOURNE   (Australia)

^cc State Research Institute Centre for Innovative Medicine   (Lithuania)

^cd AARHUS UNIVERSITY HOSPITAL   (Denmark)

^ce CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^cf INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^cg UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ch Johanniter Krankenhaus   (Germany)

^ci UNIVERSITY OF EASTERN FINLAND   (Finland)

^cj OSLO UNIVERSITY HOSPITAL   (Norway)

^ck HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^cl UNIVERSITY OF HONG KONG   (Hong Kong)

^cm Vesalius Research Center   (Belgium)

^cn CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^co Cancer Research Center of Hawaii   (United States)

^cp MAYO CLINIC   (United States)

^cq GENOME INSTITUTE OF SINGAPORE   (Singapore)

^cr VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^cs Fred Hutchinson Cancer Research Center   (United States)

^ct UNIVERSITY OF WASHINGTON   (United States)

^cu NATIONAL CANCER INSTITUTE   (Italy)

^cv TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^cw CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^cx UNIVERSITY HEALTH NETWORK   (Canada)

^cy UNIVERSITY OF TORONTO   (Canada)

^cz Clinical Molecular Geneticist and Cytogeneticist Invitae Corportation   (United States)

^da MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^db NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^dc UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^dd Seoul National University College of Medicine   (South Korea)

^de UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^df Imperial College London   (United Kingdom)

^dg FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^dh OHIO STATE UNIVERSITY   (United States)

^di UNIVERSITY OF OULU   (Finland)

^dj UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^dk CLALIT HEALTH SERVICES   (Israel)

^dl JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^dm INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^dn ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^do UNIVERSITY OF GRANADA   (Spain)

^dp CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^dq KING'S COLLEGE LONDON   (United Kingdom)

^dr UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^ds UNIVERSITY OF COLOGNE   (Germany)

^dt JOHN HUNTER HOSPITAL   (Australia)

^du UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^dv Université Laval   (Canada)

^dw HOSPICES CIVILS DE LYON   (France)

^dx LINKÖPING UNIVERSITY   (Sweden)

^dy INSTITUT CURIE   (France)

^dz UNIVERSITÉ PARIS DESCARTES   (France)

^ea NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^eb PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^ec UNIVERSITY OF PORTO   (Portugal)

^ed CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^ee UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^ef National Institutes of Health ^*  (United States)

^eg ODENSE UNIVERSITY HOSPITAL   (Denmark)

^eh LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^ei UNIVERSITY OF OXFORD   (United Kingdom)

^ej Civile MP Arezzo Hospital   (Italy)

^ek BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^el CANCER REGISTRY OF NORWAY   (Norway)

^em CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^en UNIVERSITY HOSPITAL ULM   (Germany)

^eo UNIVERSITY OF TROMSØ   (Norway)

^ep FOLKHÄLSAN RESEARCH CENTER   (Finland)

^eq STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^er UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^es HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; ESTROGEN RECEPTOR; KRUPPEL LIKE FACTOR 5; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROPLYL ISOMERASE LIKE 3; PROTEIN; TRMT61B PROTEIN; UNCLASSIFIED DRUG; WDR43 PROTEIN; BRCA1 PROTEIN, HUMAN; CYCLOPHILIN; CYCLOPHILIN J, HUMAN; TRANSFER RNA METHYLTRANSFERASE; TRMT61B PROTEIN, HUMAN;

CANCER; DISEASE INCIDENCE; ETIOLOGY; GENE EXPRESSION; GENOME; GENOTYPE; IDENTIFICATION METHOD; META-ANALYSIS; SEX HORMONE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CHROMOSOME 13Q; CHROMOSOME 2P; CHROMOSOME 2Q; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; QUANTITATIVE TRAIT LOCUS; BREAST TUMOR; CHROMOSOME 2; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MUTATION; PROCEDURES; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BRCA1 PROTEIN; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 2; CYCLOPHILINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HETEROZYGOTE; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RISK FACTORS; TRNA METHYLTRANSFERASES;

EID: 84968760294     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11375     Document Type: Article

References (49)

1. Kamangar, F., Dores, G. M. & Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 24, 2137-2150 (2006).
2. Slattery, M. L. & Kerber, R. A. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. JAMA 270, 1563-1568 (1993).
3. Michailidou, K. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353-361 (2013).
4. Easton, D. F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093 (2007).
5. Hunter, D. J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874 (2007).
6. Stacey, S. N. et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 39, 865-869 (2007).
7. Stacey, S. N. et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 40, 703-706 (2008).
8. Ahmed, S. et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet. 41, 585-590 (2009).
9. Zheng, W. et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet. 41, 324-328 (2009).
10. Thomas, G. et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet. 41, 579-584 (2009).
11. Turnbull, C. et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 42, 504-507 (2010).
12. Antoniou, A. C. et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat. Genet. 42, 885-892 (2010).
13. Fletcher, O. et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J.N.C.I 103, 425-435 (2011).
14. Haiman, C. A. et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet. 43, 1210-1214 (2011).
15. Ghoussaini, M. et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet. 44, 312-318 (2012).
16. Siddiq, A. et al. A meta-Analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet. 21, 5373-5384 (2012).
17. Garcia-Closas, M. et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 45, 392-398, 398e1-398e2 (2013).
18. Bojesen, S. E. et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet. 45, 371-384 (2013).
19. Purrington, K. S. et al. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 35, 1012-1019 (2014).
20. Michailidou, K. et al. Genome-wide association analysis of more than 120, 000 individuals identifies 15 new susceptibility loci for breast cancer. Nat. Genet. 47, 373-380 (2015).
21. Antoniou, A. C. et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res. 14, R33 (2012).
22. Couch, F. J. et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 9, e1003212 (2013).
23. Mavaddat, N. et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol. Biomarkers Prev. 21, 134-147 (2012).
24. Lakhani, S. R. et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl Cancer Inst, 90, 1138-1145 (1998).
25. Lakhani, S. R. et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin. Cancer Res. 11, 5175-5180 (2005).
26. Chenevix-Trench, G. et al. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: The Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res. 9, 104 (2007).
27. Kuchenbaecker, K. B. et al. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 16, 3416 (2015).
28. Pooley, K. A. et al. A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum. Mol. Genet. 22, 5056-5064 (2013).
29. Lin, W. Y. et al. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Hum. Mol. Genet. 24, 285-298 (2014).
30. Rhie, S. K. et al. Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells. BMC Genomics 15, 331 (2014).
31. Kasowski, M. et al. Variation in transcription factor binding among humans. Science 328, 232-235 (2010).
32. Chen, C. et al. Defining a common region of deletion at 13q21 in human cancers. Genes Chromosomes Cancer 31, 333-344 (2001).
33. Kainu, T. et al. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc. Natl Acad. Sci. USA 97, 9603-9608 (2000).
34. Petersen, G. M. et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet. 42, 224-228 (2010).
35. Wolpin, B. M. et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat. Genet. 46, 994-1000 (2014).
36. Childs, E. J. et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat. Genet. 47, 911-916 (2015).
37. Ahsan, H. et al. A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol. Biomarkers Prev. 23, 658-669 (2014).
38. Stevens, K. N. et al. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res. 72, 1795-1803 (2012).
39. Genomes Project Consortium. An integrated map of genetic variation from 1, 092 human genomes. Nature 491, 56-65 (2012).
40. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
41. Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161-169 (2008).
42. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-Analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
43. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-Analysis. Stat. Med. 21, 1539-1558 (2002).
44. Quigley, D. A. et al. The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors. Mol. Oncol. 8, 273-284 (2014).
45. Haakensen, V. D. et al. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features. BMC Med. Genomics 4, 77 (2011).
46. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
47. Aulchenko, Y. S., Ripke, S., Isaacs, A. & van Duijn, C. M. GenABEL: An R library for genome-wide association analysis. Bioinformatics 23, 1294-1296 (2007).
48. Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
49. Cerami, E. et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404 (2012).